Phathom Pharmaceuticals(PHAT) - 2025 Q2 - Quarterly Results

Exhibit 99.1 Phathom Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Updates FLORHAM PARK, N.J., August 7, 2025 — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today reported financial results for the second quarter ended June 30, 2025, and provided business updates. "The second quarter marked a significant step forward in Phathom's journey toward bec ...